首页/数据集/Supplemental Table 1 from Ceritinib Enhances the Efficacy of Trametinib in BRAF/NRAS-Wild-Type Melanoma Cell Lines

Supplemental Table 1 from Ceritinib Enhances the Efficacy of Trametinib in BRAF/NRAS-Wild-Type Melanoma Cell Lines

Figshare2018-01-01 更新2026-04-28 收录

黑色素瘤药物研发

NRAS野生型细胞研究

数据链接：

https://figshare.com/articles/dataset/Supplemental_Table_1_from_Ceritinib_Enhances_the_Efficacy_of_Trametinib_in_i_BRAF_NRAS_i_-Wild-Type_Melanoma_Cell_Lines/22505469 数据链接链接失效反馈

官方服务：

资源简介：

This file contains the raw data from the drug screen

应用场景：

创建时间：

2018-01-01

黑色素瘤药物研发

肿瘤微环境

Besides improving insulin sensitivity in type 2 diabetes, the thiazolidinedione family of compounds and the pharmacologic activation of their best characterized target PPARg has been proposed as a the

NIAID Data Ecosystem70

5-HT Reuptake Blockade Disrupts Genomic Stability-Based proteostasis to Induce Pyroptosis via Remodeling Histone Serotonylation [ChIP-seq]

组蛋白血清素化

黑色素瘤药物研发

The dual challenges of limited therapeutic options caused by de novo or acquired resistance and psychological distress in melanoma patients necessitate innovative treatment strategies. In this study,

NIAID Data Ecosystem60

A novel Chalcone derivative has antitumor activity in melanoma by inducing DNA damage through the upregulation of ROS products

黑色素瘤药物研发

ROS诱导DNA损伤

Melanoma is one of the most aggressive tumors with the remarkable characteristic of resistance to traditional chemotherapy and radiotherapy. Although targeted therapy and immunotherapy benefit advance

NIAID Data Ecosystem50

Hs 294T Cells Treated with Elesclomol Alone or in Combination with NAC Compared to DMSO Treated

黑色素瘤药物研发

转录组药物响应

We used microarrays to detail gene expression changes in Hs 294T human melanoma cells after treatment with elesclomol alone, or in combination with NAC, to aide in identifing the mechnism of action of

NIAID Data Ecosystem60

DataSheet1_β-elemene Isopropanolamine Derivative LXX-8250 Induces Apoptosis Through Impairing Autophagic Flux via PFKFB4 Repression in Melanoma Cells.docx

黑色素瘤药物研发

自噬流抑制

Melanoma is a highly aggressive skin cancer and accounts for most of the skin cancer-related deaths. The efficacy of current therapies for melanoma remains to be improved. The isopropanolamine derivat

NIAID Data Ecosystem60

Supplemental Table 1 from Ceritinib Enhances the Efficacy of Trametinib in BRAF/NRAS-Wild-Type Melanoma Cell Lines

资源简介：

相关数据集